Carfilnat 60 mg Injection
113.21$
92.47$
Carfilnat 60 mg Injection is a potent medication classified as a protease inhibitor, specifically designed for the management of multiple myeloma, a cancer that affects plasma cells in the blood. By inhibiting the activity of protease enzymes, Carfilnat disrupts the cancer cell lifecycle, effectively halting their growth and proliferation. This targeted action not only helps in controlling the disease but also enhances the overall treatment regimen for patients battling this challenging condition. It is essential for users to be aware of potential side effects, including fatigue and gastrointestinal disturbances, which may occur during treatment. Before starting Carfilnat, patients should discuss their medical history with a healthcare provider, especially if they have liver issues or are taking other medications, to avoid adverse interactions. With its innovative mechanism of action, Carfilnat represents a significant advancement in multiple myeloma therapy, offering hope to many patients. Always consult with a healthcare professional for personalized advice and to ensure the best outcomes during your treatment journey.
الكمية
Active Pharmaceutical Ingredient
Uses
• Carfilnat 60 mg injection is primarily indicated for the treatment of multiple myeloma, a cancer affecting plasma cells. These abnormal cells disrupt normal blood cell production in the bone marrow. By targeting these cells, Carfilnat helps to reduce their numbers and alleviate symptoms associated with the disease. Patients may experience improved overall health and quality of life as a result of this treatment.
• In patients diagnosed with multiple myeloma, Carfilnat 60 mg injection is utilized to manage disease progression effectively. The medication works by inhibiting the growth of malignant plasma cells, which can lead to various complications. By controlling the proliferation of these cells, Carfilnat helps to minimize symptoms such as bone pain and fatigue. This can significantly enhance the patient's ability to engage in daily activities.
• Carfilnat 60 mg injection is often employed in combination with other therapies for multiple myeloma, providing a comprehensive treatment approach. This combination can enhance the overall effectiveness of the treatment regimen. The use of Carfilnat allows healthcare providers to tailor therapy based on individual patient needs and responses. As a result, it plays a crucial role in improving treatment outcomes for those affected by this condition.
• For patients experiencing recurrent infections and anemia due to multiple myeloma, Carfilnat 60 mg injection can be a vital component of their management plan. By addressing the underlying issues caused by abnormal plasma cells, this medication helps restore balance in the bone marrow. This restoration can lead to a reduction in infection rates and improvement in hemoglobin levels. Overall, Carfilnat contributes to better management of multiple myeloma-related complications.
Benefits
Carfilnat Injection contains the active substance bortezomib, also called a ‘proteasome inhibitor. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, it can kill cancer cells. Carfilnat 60 mg is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a type of cancer affecting the lymph nodes) in patients 18 years or older. It may be used alone or together with other medicines.
Side Effects
Like all medications, Carfilnat 60 mg Injection can cause side effects, but they do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Blurred vision
• Coughing
• Chest pain
• Itching
• Numbness
• Pricking
• Burning
• Tingling sensation
• confusion
• Altered sensorium ( decreased awairness)
• Low response
• Backpain
• Comfusion
• Oliguria ( decreased urine output)
• Dizziness
• Tetany ( Twitching of muscles)
• Nausea
• Pale skin
• Ulcer sores
• Vomiting
• Unusual weight gain or unsual weight loss
Common Side Effects
• Respiratory distress
• Dark urine
• Yellowish skin
• Thickiening of bronchial secretions
• Arrhythmias ( Irregual heart beat)
How To Use
Carfilnat 60 mg Injection is given into a vein as an infusion under supervision of any health care professional only. This drug is given in frequent duration -cycle. Which will decided by your doctor as per your disease condition and certain other factors. It is available as a powder which have to be mixed with liquid to be injected into a vein over certain duration.
Safety Advice
• Alcohol: Consumption of alcohol is not recommended while using Carfilnat 60 mg Injection. Alcohol may increase or decrease the effectiveness of the medicine and also increase the risk of side effects. It is the best advice for you before consuming alcohol: you can talk with a doctor or pharmacist, and they will tell you if consumption of alcohol is safe or not.
• Kidney: Carfilnat 60 mg Injection should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Carfilnat 60 mg and report any unusual symptoms or changes in kidney function to their doctor. Your doctor may need to adjust the dose in such kidney disease patients.
• Breastfeeding: It is unknown whether Carfilnat 60 mg is excreted in human milk. If you are breastfeeding and taking this medicine. It is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Carfilnat 60 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Carfilnat 60 mg and report any unusual symptoms or changes in liver function to their doctor. Your doctor may need to adjust the dose in such liver disease patients.
• Pregnancy: Animal reproduction studies have not been conducted with Carfilnat 60 mg Vial. Carfilnat 60 mg Injection is generally considered unsafe during pregnancy. If you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Carfilnat 60 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Carfilnat 60 mg Injection will not affect your ability to drive or operate machinery. In case you experience any side effects while taking Carfilnat 60 mg such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.